09.10.25 -- Paying For Lots Of Formulation Work At Your CDMO

Isolated automation systems fragment critical data and slow key processes. Learn how an integrated approach can build a more cohesive, compliant, and efficient automation landscape.

Leveraging the expertise of a chosen clinical supply partner can be a valuable resource. Examine key considerations when partnering with a CRO in order to deliver a successful clinical supply strategy.

Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.

The EMA issued three new draft documents in July, all related to the advancement of the use of electronic technology in GMP: AI, computerized systems, and documentation. The public comment period ends Oct. 7.

Learn how a top 20 US-based pharma company achieved more capacity to meet commercial supply needs in an accelerated timeline followed by pre-approval inspection with the help of a CMO partner.

Pharmaceutical labeling demands precision. Examine key considerations for ensuring accuracy and efficiency in your process, from robust control systems to diverse printing options.

Gain insights into a “simul-spray” process pioneering for combining small and large molecules into a single, atomized drug product for inhalation administration.

Explore how Indiana’s growing pharmaceutical sector — and globally connected CDMOs — are redefining where innovation in drug development truly happens.

UpperNose™ aims to facilitate the development of molecules, ensuring a smooth transition from early-stage development to clinical trials.

Review our expertise across a wide range of global markets. Our experience in securing regulatory approvals and navigating market challenges positions us as a trusted partner.

Our dedicated team of in-house design specialists deliver insightful packaging design and practical knowledge to deliver differentiated and cost-effective packaging solutions.

With extensive industry experience in both large and small molecule parenteral drug testing, we can effectively manage your API, drug substance, and drug product stability study programs.